Startups
ARMESA
Strasbourg, France
ARMESA is a Strasbourg medical research association under the local law of Alsace-Moselle. Its current legal name is ARMESA – Association de Recherche en Médecine et Santé Publique; the former name was Association de Recherche et de Développement en Médecine et Santé Publique. GLEIF’s fully corroborated record identifies SIREN778850701, LEI969500X9FM9Z5MFSY990, creation May25,1995 and current address 1QuaiJacquesSturm,67000Strasbourg. Legal entity ACTIVE and LEI ISSUED status are distinct from confirmation of a complete current workforce. Acticor’s regulator-approved2021 registration describes it as an Alsace-law research foundation managing research money and identifies president Jean-PierreCazenave, who was not paid for that presidential mandate. The2023 statutory report independently repeats his presidency and ARMESA’s shareholding. It supports scientific work in hematology, transfusion, platelet biology and clinical biomedical research, and has also made direct biotechnology equity investments. Primary Genopole2016 annual reporting identifies an actual EUR500,000 Acticor subscription; association investment is separate from payments for research services and from its president’s personal consultancy. Acticor entered judicial liquidation inJanuary2025; this historical investment does not imply approved stroke treatment or successful current operations. Published2016/2018 author disclosures identify Marie-LouiseWiesel and EmilieRemy as research affiliates or compensated study collaborators, with historical scope and no invented current employment. An H&B institutional biography names Cazenave as ARMESA president and supplies his genuine named portrait. No independently authenticated ARMESA logo, complete current operating directory, dedicated investment fund vehicle or actual external fund close was located. Historical armesa.org email/domain appears in original academic records, but the website was unavailable at review; it is not treated as an active public corporate website.
Founded 1995
Team
Emilie RemyClinical Study Research Collaborator (historical, confirmed 2018) |
 Jean-Pierre CazenavePresident (confirmed 2021–2023; also listed in institutional biography) |
Marie-Louise WieselResearch Affiliate (historical, published 2016) |
Investments
| $—Unknown date |  Acticor Biotech | Anaxago, ARMESA |